APA (7th ed.) Citation

Wu, X., Nowakowski, K. E., Abeykoon, J. P., Manske, M., Stenson, M. J., Timm, M. M., . . . Witzig, T. E. (2021). MCIR1: A patient‐derived mantle cell lymphoma line for discovering new treatments for ibrutinib resistance. European Journal of Haematology, 107(4), 458. https://doi.org/10.1111/ejh.13682

Chicago Style (17th ed.) Citation

Wu, Xiaosheng, et al. "MCIR1: A Patient‐derived Mantle Cell Lymphoma Line for Discovering New Treatments for Ibrutinib Resistance." European Journal of Haematology 107, no. 4 (2021): 458. https://doi.org/10.1111/ejh.13682.

MLA (9th ed.) Citation

Wu, Xiaosheng, et al. "MCIR1: A Patient‐derived Mantle Cell Lymphoma Line for Discovering New Treatments for Ibrutinib Resistance." European Journal of Haematology, vol. 107, no. 4, 2021, p. 458, https://doi.org/10.1111/ejh.13682.